FDA Inspection
Cambrex Profarmaco Milano SrlCambrex Profarmaco Milano Srl – FDA Inspection, Mar 31, 2009
Record Details
This FDA Inspection record concerns Cambrex Profarmaco Milano Srl, with an inspection on March 31, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 31, 2009
- Product Type
- Drugs
View Company Profile
ID · c6818a57-db50-4737-ad33-981a70bf9c2e
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 575657
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Cambrex Profarmaco Milano Srl
7| Date | Classification | Office | Project area |
|---|---|---|---|
| November 11, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 1, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 7, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 19, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 6, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cambrex Profarmaco Milano Srl
- FDA Inspection 1193220 - 2022-11-11
- FDA Inspection 1167505 - 2021-10-01
- FDA Inspection 1091698 - 2019-05-07
- FDA Inspection 1021644 - 2017-05-19
- FDA Inspection 973972 - 2015-11-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.